GHRS
GH Research PLC
NASDAQ: GHRS · HEALTHCARE · BIOTECHNOLOGY
$20.53
+7.15% today
Updated 2026-04-30
Market cap
$1.26B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.79
Dividend yield
—
52W range
$9 – $25
Volume
0.2M
GH Research PLC (GHRS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-21.00%
ROA
-15.90%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $0.00 | $-310000.00 | — | — | — |
| 2020 | $0.00 | $-446000.00 | — | — | — |
| 2021 | $0.00 | $-9.20M | — | — | — |
| 2022 | $0.00 | $-22.46M | — | — | — |
| 2023 | $0.00 | $-35.59M | — | — | — |
| 2024 | $0.00 | $-38.96M | — | — | — |
| 2025 | $0.00 | $-48.26M | — | — | — |